Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$141 Mln
Revenue (TTM)
$64 Mln
Net Profit (TTM)
$0 Mln
ROE
0.3 %
ROCE
-- %
P/E Ratio
15.7
P/B Ratio
3.9
Industry P/E
65.05
EV/EBITDA
10.3
Div. Yield
0 %
Debt to Equity
0.3
Book Value
$--
EPS
$2.8
Face value
--
Shares outstanding
3,261,040
CFO
$17.45 Mln
EBITDA
$41.04 Mln
Net Profit
$33.03 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
| -7.8 | -32.6 | 21.7 | 120.1 | 41.8 | 20.5 | 34.7 |
|
BSE Sensex
| 5.2 | 7.3 | 8.4 | 12.8 | 16.0 | 21.5 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
| 164.7 | 10.2 | -31.5 | -25.1 | 76.5 | 45.3 | 77.1 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pro-Dex (PDEX)
|
43.1 | 141.3 | 64.1 | 9.4 | 20.1 | 28.3 | 15.7 | 3.9 |
| 13.4 | 8,749.6 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.3 | 1.4 | |
| 250.1 | 7,012.7 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 248.7 | 6,573.3 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 61.3 | 8,292.0 | 2,510.8 | 185.6 | 8.8 | 4.5 | 45.7 | 1.9 | |
| 72.1 | 8,577.6 | 12,669.0 | 407.0 | 4.0 | 11.8 | 22 | 2.4 | |
| 155.6 | 8,303.7 | 1,973.6 | -494.5 | -15.3 | -41 | -- | 9.3 | |
| 98.8 | 5,733.2 | 1,387.9 | 122.3 | 13.3 | 8.9 | 47.6 | 4.0 | |
| 280.7 | 10,662.0 | 1,240.1 | 42.2 | 4.1 | 3.6 | 257.3 | 8.8 | |
| 126.5 | 7,193.7 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.7 |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers... and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Address: 2361 McGaw Avenue, Irvine, CA, United States, 92614 Read more
CEO, President, COO & Director
Mr. Richard Lee Van Kirk Jr.
CEO, President, COO & Director
Mr. Richard Lee Van Kirk Jr.
Headquarters
Irvine, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Pro-Dex Inc (PDEX) stood at $ 83 Mln as on 31-Mar-25
The share price of Pro-Dex Inc (PDEX) is $43.12 (NASDAQ) as of 16-May-2025 16:00 EDT. Pro-Dex Inc (PDEX) has given a return of 41.81% in the last 3 years.
Pro-Dex Inc (PDEX) has a market capitalisation of $ 141 Mln as on 15-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Pro-Dex Inc (PDEX) is 3.93 times as on 15-May-2025, a 8% premium to its peers’ median range of 3.64 times.
The P/E ratio of Pro-Dex Inc (PDEX) is 15.70 times as on 15-May-2025, a 76% discount to its peers’ median range of 65.05 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Pro-Dex Inc (PDEX) and enter the required number of quantities and click on buy to purchase the shares of Pro-Dex Inc (PDEX).
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Address: 2361 McGaw Avenue, Irvine, CA, United States, 92614
The CEO & director of Mr. Richard Lee Van Kirk Jr.. is Pro-Dex Inc (PDEX), and CFO & Sr. VP is Mr. Richard Lee Van Kirk Jr..
There is no promoter pledging in Pro-Dex Inc (PDEX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,119
|
|
|
876
|
|
|
858
|
|
|
830
|
|
|
787
|
|
|
719
|
|
|
687
|
|
|
687
|
|
|
573
|
| Pro-Dex Inc. (PDEX) | Ratios |
|---|---|
|
Return on equity(%)
|
28.32
|
|
Operating margin(%)
|
20.15
|
|
Net Margin(%)
|
14.61
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Pro-Dex Inc (PDEX) was $0 Mln.
